LPL Financial
BMY.RT

LPL Financial’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

LPL Financial’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-116,860
Closed -$81K – 4208
2020
Q4 		$81K Buy
116,860
+9,959
+9% +$21.2K ﹤0.01% 3705
2020
Q3 		$241K Buy
106,901
+3,636
+4% +$10.4K ﹤0.01% 3066
2020
Q2 		$370K Sell
103,265
-3,587
-3% -$12.9K ﹤0.01% 2672
2020
Q1 		$406K Sell
106,852
-14,844
-12% -$48.9K ﹤0.01% 2237
2019
Q4 		$366K Buy
+121,696
New +$316K ﹤0.01% 2623

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

LPL Financial's BMY.RT Position: Q1 2021 in Review

LPL Financial sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 116,860 shares — an estimated $81K sold.

LPL Financial first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $406K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • LPL Financial reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • LPL Financial sold 116,860 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $81K.
  • LPL Financial first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • LPL Financial's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $406K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on LPL Financial's 13F filing for Q1 2021, filed 14 May 2021.